Building on QbD Group's Landing in Europe MedTech whitepaper, this webinar explains why EU market entry requires a fundamentally different approach than you might expect. We'll explore where home-market regulatory logic breaks down in Europe — with a specific focus on clinical evidence expectations, Notified Body interactions, and lifecycle obligations.
Register to assess your own risks, avoid costly delays, and understand what it really takes to enter Europe successfully.
Our speakers bring hands-on experience in EU regulatory affairs and clinical strategy for medical devices and IVDs. They will translate the complexities of MDR and IVDR into practical, actionable guidance you can apply directly to your EU market entry journey.
Here is the revised version without mentioning specific companies, while keeping the same strength and length:
Anne-Sophie Grell is Business Unit Manager Regulatory Affairs Medical Device at QbD Group, with over two decades of experience in medical physics, diagnostic imaging, and global medical device regulation. She holds a PhD in Physics and began her career as an MRI researcher in a cancer hospital before completing a Master’s in Medical Physics, where she supported quality control activities across imaging and radiotherapy.
In 2010, she transitioned to the private sector, taking on leadership roles in Quality and Regulatory Affairs within the medical device industry. Over the years, she has worked closely with Competent Authorities and Notified Bodies worldwide, shaping international registration strategies and regulatory pathways. At QbD, she supports manufacturers in defining and executing robust regulatory strategies to successfully bring their medical devices to the European, US, and Asian markets.
Petra is a Clinical Evidence and Safety Lead at QbD Group with over 12 years of experience across clinical practice, clinical research, and the medical device industry. She holds a Master’s degree in Sports Physiotherapy and spent 10 years in clinical practice supporting both professional and non-professional athletes before transitioning into Clinical Research, where she took on roles in Clinical Operations and Safety Management. She later served as Clinical Evaluation Lead for a medical imaging device manufacturer. At QbD, Petra combines her expertise in clinical safety and evidence generation with strategic support for manufacturers in building robust clinical documentation and navigating EU MDR requirements to successfully bring their products to the European market.
Keeping up with the fast-paced life sciences industry doesn’t have to be overwhelming.
Our newsletter delivers the latest insights, industry updates, and expert content directly to your inbox, helping you stay informed and make smarter decisions.
